Zenas BioPharma’s $118 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised lead investor Enavate Sciences and new investor Longitude Capital in the financing.Global pharmaceutical company Zenas BioPharma announced a $118 million…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now